CARDIOMYOPATHY, SECONDARY
Clinical trials for CARDIOMYOPATHY, SECONDARY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, SECONDARY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, SECONDARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First gene therapy trial targets deadly heart damage in rare neurological disease
Disease control OngoingThis early-stage study is testing a new gene therapy, LX2006, for people with Friedreich's ataxia who have developed heart muscle damage. The therapy aims to deliver a healthy gene directly to heart cells to improve their function. Researchers will first check if the treatment is…
Matched conditions: CARDIOMYOPATHY, SECONDARY
Phase: PHASE1, PHASE2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Global heart study aims to stop pacemakers from harming hearts
Disease control OngoingThis large international study aims to improve treatment for people receiving heart devices like pacemakers. Researchers want to identify which patients are most at risk of developing heart damage from their devices before implantation happens. By creating a personalized risk sco…
Matched conditions: CARDIOMYOPATHY, SECONDARY
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC